fludarabine has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aquaro, S; Balestra, E; Casabianca, A; Cervasi, B; Fraternale, A; Garaci, E; Magnani, M; Paiardini, M; Perno, CF | 1 |
Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF | 1 |
2 other study(ies) available for fludarabine and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression.
Topics: Acquired Immunodeficiency Syndrome; Acute-Phase Proteins; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Cell Survival; Cells, Cultured; Disease Reservoirs; DNA-Binding Proteins; Erythrocytes; HIV-1; Humans; Leukocytes, Mononuclear; Macrophages; Proviruses; STAT3 Transcription Factor; Trans-Activators; Vidarabine; Viral Load; Virus Replication | 2003 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load | 2002 |